Additionally, the identification of gene sets co-expressed with NRP isoforms offers potential biomarkers for cancer diagnosis and prognosis, as well as therapeutic targets to reprogram TAMs and disrupt their pro-tumorigenic functions (59). This evidence concerns the gene NRP1 and cancer.